Velan Capital Investment Management Lp Top Holdings and 13F Report (2026) About Velan Capital Investment Management LpInvestment ActivityVelan Capital Investment Management Lp has $104.74 million in total holdings as of September 30, 2026.Velan Capital Investment Management Lp owns shares of 43 different stocks, but just 11 companies or ETFs make up 80% of its holdings.Approximately 6.93% of the portfolio was purchased this quarter.About 20.37% of the portfolio was sold this quarter.This quarter, Velan Capital Investment Management Lp has purchased 50 new stocks and bought additional shares in 5 stocks.Velan Capital Investment Management Lp sold shares of 6 stocks and completely divested from 13 stocks this quarter.Largest Holdings PRAXIS PRECISION MEDICINES I $22,308,218Immix Biopharma $11,289,425Protara Therapeutics $8,676,189SUTRO BIOPHARMA INC $8,216,712ABIVAX SA $6,498,683 Largest New Holdings this Quarter 28036F105 - Edgewise Therapeutics $1,390,550 Holding746964105 - Q32 BIO INC $992,400 Holding002942100 - AARDVARK THERAPEUTICS INC $452,524 Holding98887Q104 - Zai Lab $237,060 Holding29251M106 - Enanta Pharmaceuticals $197,700 Holding Largest Purchases this Quarter EDESA BIOTECH INC 454,545 shares (about $1.91M)Edgewise Therapeutics 34,250 shares (about $1.39M)MAPLIGHT THERAPEUTICS INC 131,810 shares (about $1.34M)Q32 BIO INC 120,000 shares (about $992.40K)InspireMD 776,542 shares (about $518.57K) Largest Sales this Quarter PRAXIS PRECISION MEDICINES I 12,181 shares (about $3.55M)Xencor 80,000 shares (about $2.00M)C4 Therapeutics 500,000 shares (about $1.67M)TENAX THERAPEUTICS INC 549,985 shares (about $1.04M)LYELL IMMUNOPHARMA INC 90,000 shares (about $881.10K) Sector Allocation Over TimeMap of 500 Largest Holdings ofVelan Capital Investment Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorPRAXIS PRECISION MEDICINES I$22,308,218$3,547,473 ▼-13.7%76,60021.3%COM NEWIMMXImmix Biopharma$11,289,4250.0%1,085,00010.8%HealthcareTARAProtara Therapeutics$8,676,1890.0%2,844,6528.3%HealthcareSUTRO BIOPHARMA INC$8,216,712$34,185 ▼-0.4%510,0387.8%COM SHSABIVAX SA$6,498,6830.0%65,6306.2%SPONSORED ADSMAPLIGHT THERAPEUTICS INC$6,365,724$1,343,144 ▲26.7%624,7036.1%COMANTERIS TECHNOLOGIES GLOBAL$5,439,0000.0%700,0005.2%COMEDESA BIOTECH INC$5,397,409$1,913,634 ▲54.9%1,282,0455.2%COM NEWAVALO THERAPEUTICS INC$4,973,8490.0%324,4524.7%COM NEWXNCRXencor$4,366,250$1,996,000 ▼-31.4%175,0004.2%HealthcareEVOMMUNE INC$3,768,666$41,300 ▲1.1%456,2553.6%COM SHSEUPRAXIA PHARMACEUTICALS INC$3,203,2000.0%352,0003.1%COMHRTXHeron Therapeutics$2,744,1560.0%8,753,2902.6%HealthcareEWTXEdgewise Therapeutics$1,390,550$1,390,550 ▲New Holding34,2501.3%HealthcareREIN THERAPEUTICS INC$1,366,8000.0%1,700,0001.3%COM NEWNASUS PHARMA LTD$1,326,1490.0%359,3901.3%ORD SHSQ32 BIO INC$992,400$992,400 ▲New Holding120,0000.9%COMNSPRInspireMD$617,501$518,574 ▲524.2%924,6800.6%HealthcarePTGXProtagonist Therapeutics$521,2930.0%3,7000.5%HealthcareAARDVARK THERAPEUTICS INC$452,524$452,524 ▲New Holding85,8680.4%COMNRIXNurix Therapeutics$379,3600.0%16,0000.4%HealthcareCTMXCytomX Therapeutics$326,4000.0%120,0000.3%HealthcareOVIDOvid Therapeutics$323,7000.0%130,0000.3%HealthcareMLYSMineralys Therapeutics$276,4300.0%11,0000.3%HealthcareREPLReplimune Group$264,8000.0%20,0000.3%HealthcarePRECISION BIOSCIENCES INC$250,4000.0%40,0000.2%COM NEWZLABZai Lab$237,060$237,060 ▲New Holding9,0000.2%HealthcareCCCCC4 Therapeutics$233,100$1,665,000 ▼-87.7%70,0000.2%HealthcareMGNXMacroGenics$231,6000.0%60,0000.2%HealthcareIMNMImmunome$215,1000.0%10,0000.2%HealthcareAN2 THERAPEUTICS INC$212,8000.0%40,0000.2%COMVRDNViridian Therapeutics$205,9000.0%10,0000.2%HealthcareCRBPCorbus Pharmaceuticals$204,600$27,280 ▲15.4%30,0000.2%HealthcareENTAEnanta Pharmaceuticals$197,700$197,700 ▲New Holding15,0000.2%HealthcareSCYNEXIS INC$197,6000.0%40,0000.2%COMARTIVA BIOTHERAPEUTICS INC$178,0000.0%25,0000.2%COMRCKTRocket Pharmaceuticals$157,8000.0%60,0000.2%HealthcareLYELL IMMUNOPHARMA INC$146,850$881,100 ▼-85.7%15,0000.1%COM NEWJADE BIOSCIENCES INC$140,500$140,500 ▲New Holding10,0000.1%COM NEWNEUMORA THERAPEUTICS INC.$137,1260.0%230,0000.1%COMTENAX THERAPEUTICS INC$129,843$1,039,472 ▼-88.9%68,7000.1%COM NEWLRMRLarimar Therapeutics$105,4350.0%33,0000.1%HealthcareKALARIS THERAPEUTICS INC$72,2500.0%25,0000.1%COMRZLTRezolute$0$3,900,000 ▼-100.0%00.0%HealthcareVERRICA PHARMACEUTICALS INC$0$2,885,941 ▼-100.0%00.0%COM SHSADMAADMA Biologics$0$2,092,500 ▼-100.0%00.0%HealthcarePROFProfound Medical$0$1,132,349 ▼-100.0%00.0%HealthcareJASPER THERAPEUTICS INC$0$1,123,394 ▼-100.0%00.0%COM NEWSNDXSyndax Pharmaceuticals$0$218,600 ▼-100.0%00.0%HealthcareTECTONIC THERAPEUTIC INC$0$206,250 ▼-100.0%00.0%COMKARYOPHARM THERAPEUTICS INC$0$195,400 ▼-100.0%00.0%COM NEWQUOIN PHARMACEUTICALS LTD$0$156,680 ▼-100.0%00.0%SPONSORED ADSXILIO THERAPEUTICS INC$0$136,850 ▼-100.0%00.0%COMPRQRProQR Therapeutics$0$83,700 ▼-100.0%00.0%HealthcareCNTXContext Therapeutics$0$33,068 ▼-100.0%00.0%HealthcareGOSSGossamer Bio$0$11,522 ▼-100.0%00.0%HealthcareShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.